Currently approved AD drugs including acetylcholinesterase inhibitors (donepezil) and N-methyl-d-aspartate receptor (NMDAR) antagonists (memantine hydrochloride) prescribed for relieving symptoms, however, are not able to improve the situation of neuronal cell death [45,46]. Here, ACHE is linked to Alzheimer disease.